Voyager Therapeutics: Q3 Earnings Snapshot

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $9 million in its third quarter.

On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 16 cents.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.

The gene therapy company posted revenue of $24.6 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $12.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up